Ex Vivo Lentiviral Gene Therapy as a Cure for Murine Pompe Disease

被引:0
|
作者
Stok, Merel [1 ]
de Boer, Helen [1 ]
Huston, Marshall W. [1 ]
Jacobs, Edwin H. [1 ]
Roovers, Onno [1 ]
Jahr, Holger [1 ]
Duncker, Dirk J. [1 ]
Visser, Trudi P. [1 ]
van der Ploeg, Ans T. [2 ]
Reuser, Arnold J. J. [2 ]
van Til, Nico P. [1 ]
Wagemaker, Gerard [1 ]
机构
[1] Erasmus MC, Rotterdam, Netherlands
[2] Erasmus MC, Ctr Lysosomal & Metab Dis, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
275
引用
收藏
页码:S105 / S105
页数:1
相关论文
共 50 条
  • [1] Lentiviral ex vivo gene therapy to the murine model of MPSII
    Wakabayashi, Taichi
    Kobayashi, Hiroshi
    Shimada, Yohta
    Higuchi, Takashi
    Eto, Yoshikatsu
    Ida, Hiroyuki
    Ohashi, Toya
    [J]. HUMAN GENE THERAPY, 2014, 25 (11) : A64 - A64
  • [2] Lentiviral gene therapy for Pompe disease
    Stok, M.
    de Boer, H.
    de Visser, T. P.
    Reuser, A. J.
    Jacobs, E.
    Jahr, H.
    Duncker, D.
    van Til, N. P.
    Wagemaker, G.
    [J]. HUMAN GENE THERAPY, 2011, 22 (10) : A40 - A41
  • [3] Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease
    Stok, Merel
    de Boer, Helen
    Huston, Marshall W.
    Jacobs, Edwin H.
    Roovers, Onno
    Visser, Trudi P.
    Jahr, Holger
    Duncker, Dirk J.
    van Deel, Elza D.
    Reuser, Arnold J. J.
    van Til, Niek P.
    Wagemaker, Gerard
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 1014 - 1025
  • [4] Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype
    van Til, Niek P.
    Stok, Merel
    Kaya, Fatima S. F. Aerts
    de Waard, Monique C.
    Farahbakhshian, Elnaz
    Visser, Trudi P.
    Kroos, Marian A.
    Jacobs, Edwin H.
    Willart, Monique A.
    van der Wegen, Pascal
    Scholte, Bob J.
    Lambrecht, Bart N.
    Duncker, Dirk J.
    van der Ploeg, Ans T.
    Reuser, Arnold J. J.
    Verstegen, Monique M.
    Wagemaker, Gerard
    [J]. BLOOD, 2010, 115 (26) : 5329 - 5337
  • [5] Lentiviral stem cell gene therapy for Pompe disease
    Liang, Qiushi
    van Helsdingen, Yvette
    van der Velden, Guus
    Stok, Merel
    Jacobs, Ed
    Duncker, Dirk
    Reuser, Arnold
    van der Ploeg, Ans
    Vulto, Arnold
    van Til, Niek P.
    Wagemaker, Gerard
    [J]. HUMAN GENE THERAPY, 2014, 25 (11) : A62 - A63
  • [6] LENTIVIRAL GENE THERAPY OF MURINE HEMATOPOIETIC STEM CELLS LEADS TO CORRECTION OF THE POMPE DISEASE PHENOTYPE
    Stok, M.
    van Til, N. P.
    Kaya, F. S. F. Aerts
    Farahbakhshian, E.
    Visser, T. P.
    Kroos, M. A.
    de Waard, M. C.
    Jacobs, E. H.
    Willart, M. A.
    van der Wegen, P.
    Scholte, B. J.
    Lambrecht, B. N.
    Duncker, D. J.
    van der Ploeg, A. T.
    Reuser, A. J. J.
    Verstegen, M. V.
    Wagemaker, G.
    [J]. CLINICAL THERAPEUTICS, 2010, 32 : S81 - S81
  • [7] NEONATAL GENE THERAPY USING LENTIVIRAL VECTOR SYSTEM FOR MURINE POMPE DISEASE: LONG TERM EFFICACY
    Kyosen, Sandra Obikawa
    Iizuka, Sayoko
    Kimura, Takahiro
    Kobayashi, Hiroshi
    Fukuda, Takahiro
    Ida, Hiro-yuki
    Eto, Yoshikatsu
    Ohashi, Toya
    [J]. JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1022 - 1023
  • [8] Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe Disease
    Piras, Giuseppa
    Montiel-Equihua, Claudia
    Chan, Yee-Ka Agnes
    Wantuch, Slawomir
    Stuckey, Daniel
    Burke, Derek
    Prunty, Helen
    Phadke, Rahul
    Chambers, Darren
    Partida-Gaytan, Armando
    Leon-Rico, Diego
    Panchal, Neelam
    Whitmore, Kathryn
    Calero, Miguel
    Benedetti, Sara
    Santilli, Giorgia
    Thrasher, Adrian J.
    Gaspar, H. Bobby
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 18 : 558 - 570
  • [9] Ex vivo lentiviral gene therapy for mucopolysaccharidosis type IVA
    Celik, Betul
    Rintz, Estera
    Nidhi, Fnu
    Khan, Shaukat
    Tomatsu, Shunji
    [J]. MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [10] Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
    Kohn, D. B.
    Booth, C.
    Shaw, K. L.
    Xu-Bayford, J.
    Garabedian, E.
    Trevisan, V.
    Carbonaro-Sarracino, D. A.
    Soni, K.
    Terrazas, D.
    Snell, K.
    Ikeda, A.
    Leon-Rico, D.
    Moore, T. B.
    Buckland, K. F.
    Shah, A. J.
    Gilmour, K. C.
    De Oliveira, S.
    Rivat, C.
    Crooks, G. M.
    Izotova, N.
    Tse, J.
    Adams, S.
    Shupien, S.
    Ricketts, H.
    Davila, A.
    Uzowuru, C.
    Icreverzi, A.
    Barman, P.
    Fernandez, B. Campo
    Hollis, R. P.
    Coronel, M.
    Yu, A.
    Chun, K. M.
    Casas, C. E.
    Zhang, R.
    Arduini, S.
    Lynn, F.
    Kudari, M.
    Spezzi, A.
    Zahn, M.
    Heimke, R.
    Labik, I.
    Parrott, R.
    Buckley, R. H.
    Reeves, L.
    Cornetta, K.
    Sokolic, R.
    Hershfield, M.
    Schmidt, M.
    Candotti, F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21): : 2002 - 2013